PANASONIC-CORPORATION
Panasonic Corporation announced the successful completion of its 100 Thousand Solar Lanterns Project, which has brought light to off-grid communities in 30 countries through 131 non-profit and other organizations in the last five years. Since the project's inception in February 2013, a total of 102,716 solar lanterns have been donated, including 5,004 lanterns given today to Indonesia, which has marked the end of the project.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180208005520/en/
The project was part of Panasonic's Corporate Social Responsibility (CSR) initiatives that make use of its technologies and products in line with the company's management philosophy since its founding in 1918, that is, to make a contribution to the progress and development of society and the well-being of people through its business activities.
There are estimated 1.1 billion people who live without electricity in emerging and developing countries. Panasonic's project got started with the aim to help solve social issues stemming from a lack of light in the fields of medicine, education and economy, among others. Panasonic has strived towards the goal of donating a total of 100,000 units of solar lanterns by 2018, its centenary year .
Panasonic's lanterns, which were brought to communities in cooperation with non-profit, non-governmental and other international organizations, helped alleviate problems and brought about improvements in such areas as education, health and medicine, and women's independence. The solar lanterns have also contributed to the Sustainable Development Goals (SDGs) set by the United Nations to mobilize global efforts to end poverty, protect the planet and ensure prosperity.
With the completion of the 100 Thousand Solar Lanterns Project, Panasonic now carries on its efforts to deliver more light to people in regions without access to electricity in a new framework. In Japan, Panasonic employees took part in the project through its employee benefit program . In addition to this, to expand the activity beyond the company, Panasonic will begin utilizing crowdfunding this April to enable anyone who shares the spirit of this campaign to participate by pledging a small amount of money.
Ms. Rika Fukuda, General Manager, CSR & Citizenship Group of Panasonic, which led the project, said: "We are very pleased to achieve the 100,000 goal. As a global corporate citizen, we remain committed to helping people living without electricity solve problems, with the aim to build an inclusive society where everyone enjoys life by sharing the joy with each other." The company will also continue contributing to SDGs through activities that utilize its business, she added.
Summary of activities
Major
Outcomes of the Project Contributing to the UN’s SDGs
1.
“Affordable and clean energy”
- Reduced use of kerosene lamps by
37.7% (Myanmar)
2. “Good health and well-being”
- 2,434
children born in rooms well-lit by lanterns (Myanmar)
3. “Quality
education”
- 100% pass rate in school tests for progressing to next
academic level (Myanmar)
4. “Gender equality”
- Approximately
40% increase in income due to increased opportunities for women such as
working at night (India)
5. “No poverty”
- Fuel costs for
kerosene lamps are reduced by 50% per month (Cambodia)
Sustainable Development Goals
Sustainable Development Goals
are a set of goals adopted by countries at a special United Nations
summit in September 2015 for the period from 2016 to 2030. The SDGs
comprise of 17 goals and 169 targets aimed at realizing sustainability,
and it is the UN's intention that no one should be left behind. The SDGs
are universal, and require the combined effort from all nations,
developing and advanced.
Source: http://news.panasonic.com/global/stories/2018/54520.html
Related Links
100 THOUSAND SOLAR LANTERNS PROJECT
http://panasonic.net/sustainability/en/lantern/
About the BG-BL03 solar lanterns donated to Indonesia
http://panasonic.net/sustainability/en/lantern/products.html
100 THOUSAND SOLAR LANTERNS PROJECT Facebook page
https://www.facebook.com/PanasonicSolarLantern
Panasonic's Sustainability Initiatives
https://www.panasonic.com/global/corporate/sustainability.html
Panasonic Donates 1,200 Solar Lanterns to Central Vietnam (Oct 16, 2017)
http://news.panasonic.com/global/stories/2017/51655.html
Panasonic Donates 3,060 Solar Lanterns to Humanitarian &
Non-Governmental Organizations in Myanmar Bringing Total Number of
Donations to 14,924 Throughout 5 Years (Sep 20, 2017)
http://news.panasonic.com/global/stories/2017/50858.html
Panasonic Donates Over 2,000 Solar Lanterns to Cambodian NPOs, Bringing
Total Number of Donations to 13,516 Throughout Five Years (Aug 30, 2017)
http://news.panasonic.com/global/stories/2017/50228.html
View source version on businesswire.com: http://www.businesswire.com/news/home/20180208005520/en/
Contact:
Panasonic Corporation
Global Communications Department
Global
PR Office
Click
here to go to Media Contact form
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom